"Advance commercial strategy for trofinetide ex-North America using US data for registration"
I guess that means there's no immediate takeover...
Ann: 5 Orphan Drug programs and Rett in Phase 3 funded by partner, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.92 |
Change
-0.040(0.31%) |
Mkt cap ! $1.609B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.70 | $2.031M | 157.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 556 | $12.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.93 | 156 | 9 |
View Market Depth
| Last trade - 12.48pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |